Collaborative investigation of variables in susceptibility testing of yeasts.
about
Current and emerging azole antifungal agentsIn vitro studies of activities of some antifungal agents against Candida albicans ATCC 10231 by the turbidimetric methodFluconazole susceptibility testing of Candida albicans: microtiter method that is independent of inoculum size, temperature, and time of readingPotential use of BacT/Alert automated blood culture system for antifungal susceptibility testing.History of medical mycology in the united states.Effects of antifungal interventions on the outcome of experimental infections with phenotypic switch variants of Cryptococcus neoformans.Improved medium for fluconazole susceptibility testing of Candida albicans.Fluconazole and platelet microbicidal protein inhibit Candida adherence to platelets in vitro.Fluconazole susceptibilities of bloodstream Candida sp. isolates as determined by National Committee for Clinical Laboratory Standards method M27-A and two other methodsQuantitation of ergosterol content: novel method for determination of fluconazole susceptibility of Candida albicansIn vitro comparison of activities of terbinafine and itraconazole against Paracoccidioides brasiliensis.Comparative evaluation of PASCO and national committee for clinical laboratory standards M27-A broth microdilution methods for antifungal drug susceptibility testing of yeastsAnalysis of growth characteristics of filamentous fungi in different nutrient media.Quantitation of Candida albicans ergosterol content improves the correlation between in vitro antifungal susceptibility test results and in vivo outcome after fluconazole treatment in a murine model of invasive candidiasis.Comparative evaluation of NCCLS M27-A and EUCAST broth microdilution procedures for antifungal susceptibility testing of candida species.Comparative and collaborative evaluation of standardization of antifungal susceptibility testing for filamentous fungi.Correlation between rhodamine 123 accumulation and azole sensitivity in Candida species: possible role for drug efflux in drug resistance.Microdilution antifungal susceptibility testing of Candida albicans and Cryptococcus neoformans with and without agitation: an eight-center collaborative studyRandomly amplified polymorphic DNA as a valuable tool for epidemiological studies of Paracoccidioides brasiliensis.Impact of the changing epidemiology of fungal infections in the 1990s.Intra- and interlaboratory study of a method for testing the antifungal susceptibilities of dermatophytesMulticenter evaluation of a broth macrodilution antifungal susceptibility test for yeastsThrombin-induced rabbit platelet microbicidal protein is fungicidal in vitro.Effects of temperature on anti-Candida activities of antifungal antibiotics.Fluconazole resistance in Candida glabrataStandardized susceptibility testing of fluconazole: an international collaborative study.Susceptibilities of Norwegian Candida albicans strains to fluconazole: emergence of resistance. The Norwegian Yeast Study GroupCorrelation of in vitro fluconazole resistance of Candida isolates in relation to therapy and symptoms of individuals seropositive for human immunodeficiency virus type 1.Susceptibility testing of fungi: current status of the standardization process.Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for azole antifungal susceptibility testing.Effect of increasing inoculum sizes of pathogenic filamentous fungi on MICs of antifungal agents by broth microdilution methodComparison of two alternative microdilution procedures with the National Committee for Clinical Laboratory Standards reference macrodilution method M27-P for in vitro testing of fluconazole-resistant and -susceptible isolates of Candida albicans.Susceptibility testing of fungi: current status of correlation of in vitro data with clinical outcome.Interlaboratory evaluation of Etest method for testing antifungal susceptibilities of pathogenic yeasts to five antifungal agents by using Casitone agar and solidified RPMI 1640 medium with 2% glucoseFluconazole disk diffusion procedure for determining susceptibility of Candida species.Invasive Nattrassia mangiferae infections: case report, literature review, and therapeutic and taxonomic appraisal.Rapid flow cytometric susceptibility testing of Candida albicansFunctions and activities of the Area Committee on Microbiology of the National Committee for Clinical Laboratory Standards.Modulation of interactions of Candida albicans and endothelial cells by fluconazole and amphotericin B.Two-site comparison of broth microdilution and semisolid agar dilution methods for susceptibility testing of Cryptococcus neoformans in three media.
P2860
Q24550733-2B9840E3-E0F4-4156-B029-27E2595DDEA3Q28318358-18DCEEFD-1C28-4A2D-A639-2B2A3BF69B0AQ28326328-B13EA824-1F0C-4127-BD4C-43BC3E4D99CEQ30451507-94FE12FF-8DEA-4366-8176-85885089182EQ30452877-8E760172-8661-42AB-B353-71E1DAD2A9AFQ33556039-7E7829AD-2F9C-40B5-BD78-79FCB2920DE4Q33747088-759CC5CE-6755-470E-B428-11AA85CDC031Q33754045-4AFF69D8-955D-424A-B6A9-03F7620B528CQ33961413-302E1B7E-C5B6-4930-83EE-02E62B634C17Q33963057-426B4B69-3E2F-40D6-B843-A17F32474305Q33965202-1E65A09B-D0C8-4AF0-B155-5A5E51D81F6BQ33967445-714333F7-B9AC-4E0E-A8FC-38F02240C8F7Q33971124-4A16172B-573C-45B4-9F4A-608F47551100Q33980195-574E5491-8DC7-46AC-A04E-AB50F9ED2FC4Q34142465-C09F01CE-0C80-4AB1-8925-FBF8B1F55CB3Q35111403-9EAC08BA-F877-49EA-A1AC-63DF7AFCEC75Q35122459-ED2B1EC3-78F2-481C-8453-1AF7D9070C96Q35128351-9863B769-4F34-47D2-A5F9-1B8D41F4DB85Q35156183-CCAFF486-EBE2-4945-822F-3533B06340B2Q35375775-C542B3E1-C833-40B6-A72B-832513531585Q35713867-39463658-C8FE-44D1-A0D3-3BB09C95DB8FQ35807502-4A1B78BB-FC46-4123-8728-C54BD8AA8BABQ35810470-EEAEF277-E493-47F2-96B6-88715D9F52E7Q35811074-4E290A43-E2C6-4AFF-8A57-702CA6FFF798Q35819599-8C6F04E7-715F-4D2B-9BA9-A93803362715Q35896738-E6E3F3F1-DA1A-4F37-B58C-D398DC5F198AQ35900191-85F7E0D2-82CF-4508-9F7A-FB45582661DEQ35900199-E9019657-AC51-4CC3-8342-5924B2497C87Q35903839-77AD7CD8-0D53-46BE-BB27-ED96FF936088Q36519221-D6DBF19D-6AFB-4928-AEE1-F399AB98C7F9Q36522007-BC3D724F-A385-48DD-9835-ADE322E69348Q36526361-FB3C121E-B1C3-49D3-98E7-78DBEE7CFC76Q36528018-2C115561-EC00-46DA-8E08-9855931AFF85Q36529935-4D0E346E-B4FC-4BFF-B02E-348AF63D9F5DQ36537557-94FFD876-EE38-4775-8282-C5C59086917AQ36543126-B24C4161-FDC2-4A41-ACDB-BB82643DF309Q36546384-0C51F331-EB8D-4E1C-8FF4-DF3253615AF2Q36637210-5171494F-1272-4EFD-9CCB-35E250670FE1Q36757860-20352036-F45D-46D0-B647-6AD38C977F9AQ37068914-70ACFDBB-AF1A-48E1-B532-DEDE9ECE706D
P2860
Collaborative investigation of variables in susceptibility testing of yeasts.
description
1990 nî lūn-bûn
@nan
1990 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Collaborative investigation of variables in susceptibility testing of yeasts.
@ast
Collaborative investigation of variables in susceptibility testing of yeasts.
@en
type
label
Collaborative investigation of variables in susceptibility testing of yeasts.
@ast
Collaborative investigation of variables in susceptibility testing of yeasts.
@en
prefLabel
Collaborative investigation of variables in susceptibility testing of yeasts.
@ast
Collaborative investigation of variables in susceptibility testing of yeasts.
@en
P2093
P2860
P356
P1476
Collaborative investigation of variables in susceptibility testing of yeasts.
@en
P2093
Bartlett MS
Espinel-Ingroff A
Fromtling RA
Galgiani JN
Pfaller MA
Rinaldi MG
P2860
P304
P356
10.1128/AAC.34.9.1648
P407
P577
1990-09-01T00:00:00Z